In this episode of The Onco’Zine Brief, developed in collaboration with ADC Review | Journal of Antibody-drug Conjugates (at www.ADCReview.com), Peter Hofland, Ph.D. talks with William (Bill) Newell, JD, Chief Executive Officer and a member of the Board of Directors of Sutro Biopharma (www.sutrobio.com) Sutro is a clinical-stage drug discovery, development, and manufacturing company using precise […]

Peripheral nerve damage is estimated to affect more than 20 million people in theUnited States, causing symptoms that range from mild discomfort to severe disability. Damage is often undiagnosed or untreated, and current standard of care procedures can be associated with limitations that impact quality of life. Axogen, a company focused on the science, development, […]

Osteoarthritis is a painful, progressive disease of the joints for which there is no cure. The condition affects more than 32.5 million adults in the United State and the incidence is growing as a result of aging, obesity, and sports injuries. Flexion Therapeutics is developing an experimental gene therapy to treat the condition. Rather than […]